Related Experiment Videos
Diabetes screening anxiety and beliefs
T C Skinner1, M J Davies, A M Farooqi
1School of Psychology, University of Southampton, Highfield, Southhampton SO17 1BJ, Hampshire, UK. t.c.skinner@soton.ac.uk
Diabetic Medicine : a Journal of the British Diabetic Association
|October 26, 2005
Summary
Diabetes screening does not significantly increase anxiety. Anxiety scores were linked to perceptions of diabetes seriousness and emotional stability, not screening itself.
Area of Science:
- Medical Research
- Psychology
- Public Health
Background:
- Screening for diabetes is a key public health intervention.
- Understanding psychological impacts, such as anxiety, is crucial for effective screening programs.
- Exploring the role of beliefs about diabetes and personality traits can offer insights into anxiety responses.
Purpose of the Study:
- To evaluate the effect of diabetes screening on anxiety levels in a diverse UK population.
- To investigate if beliefs about Type 2 diabetes influence anxiety during screening.
- To identify factors associated with anxiety in individuals at high risk for diabetes.
Main Methods:
- A cross-sectional study involving 1339 participants at high risk for diabetes.
- Participants underwent an oral glucose tolerance test (OGTT).
- Anxiety and illness perception were measured using validated scales, including the Spielberger State Anxiety Scale and the Diabetes Illness Representations Questionnaire.
Main Results:
- No significant impact of family history, ethnicity, or recruitment method on anxiety levels was found.
- Emotional stability was the only variable significantly and negatively associated with anxiety.
- A minority of participants perceived diabetes as a serious, life-shortening condition.
Conclusions:
- Diabetes screening does not appear to induce significant anxiety.
- Perceptions of diabetes seriousness and the personality trait of emotional stability are key predictors of anxiety.
- Further research may explore interventions to manage anxiety related to diabetes perceptions.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...